Cargando…

Functions and clinical significance of KLRG1 in the development of lung adenocarcinoma and immunotherapy

BACKGROUND: As a marker of differentiation, Killer cell lectin like receptor G1 (KLRG1) plays an inhibitory role in human NK cells and T cells. However, its clinical role remains inexplicit. This work intended to investigate the predictive ability of KLRG1 on the efficacy of immune-checkpoint inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xiaodong, Zheng, Yuexin, Han, Zhihai, Zhang, Xiliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243757/ https://www.ncbi.nlm.nih.gov/pubmed/34187403 http://dx.doi.org/10.1186/s12885-021-08510-3

Ejemplares similares

A Protocol for the Production of KLRG1 Tetramer
por: Terrizzi, Stephanie C., et al.
Publicado: (2010)

KLRG1 restricts memory T cell antitumor immunity
por: Li, Lei, et al.
Publicado: (2016)

KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response
por: Ager, Casey R, et al.
Publicado: (2023)

The Yin and Yang of Targeting KLRG1(+) Tregs and Effector Cells
por: Borys, Samantha M., et al.
Publicado: (2022)

PD-1 regulates KLRG1(+) group 2 innate lymphoid cells
por: Taylor, Samuel, et al.
Publicado: (2017)

Increased KLRG1 and PD-1 expression on CD8 T lymphocytes in TB-IRIS
por: Goovaerts, Odin, et al.
Publicado: (2019)

KLRG1(+) natural killer cells protect against pulmonary metastatic disease by immunosurveillance
por: Renner, Philipp, et al.
Publicado: (2014)

Functional and clinical significance of ROR1 in lung adenocarcinoma
por: Giovanna, Schiavone, et al.
Publicado: (2020)

Ptpn2 and KLRG1 regulate the generation and function of tissue-resident memory CD8(+) T cells in skin
por: Hochheiser, Katharina, et al.
Publicado: (2021)

Combination blockade of KLRG1 and PD-1 promotes immune control of local and disseminated cancers
por: Tata, Angela, et al.
Publicado: (2021)

Early primed KLRG1(-) CMV-specific T cells determine the size of the inflationary T cell pool
por: Baumann, Nicolas S., et al.
Publicado: (2019)

Expression of IL‐7Rα and KLRG1 defines functionally distinct CD8(+) T‐cell populations in humans
por: Remmerswaal, Ester B. M., et al.
Publicado: (2019)

Correction to: Functional and clinical significance of ROR1 in lung adenocarcinoma
por: Schiavone, Giovanna, et al.
Publicado: (2020)

Allogeneic dendritic cells induce potent antitumor immunity by activating KLRG1(+)CD8 T cells
por: Wang, Chao, et al.
Publicado: (2019)

PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127(+) and KLRG1(+) CD8 T cells
por: Hui, Zhenzhen, et al.
Publicado: (2023)

Co-inhibitory T cell receptor KLRG1: human cancer expression and efficacy of neutralization in murine cancer models
por: Greenberg, Steven A., et al.
Publicado: (2019)

Reduced Ebola vaccine responses in CMV(+) young adults is associated with expansion of CD57(+)KLRG1(+) T cells
por: Bowyer, Georgina, et al.
Publicado: (2020)

In Vivo Zymosan Treatment Induces IL15-Secreting Macrophages and KLRG1-Expressing NK Cells in Mice
por: Park, Hyun Jung, et al.
Publicado: (2023)

Enhanced protection conferred by mucosal BCG vaccination associates with presence of antigen-specific lung tissue-resident PD-1(+) KLRG1(−) CD4(+) T cells
por: Bull, N. C., et al.
Publicado: (2018)

Clinical significance of cripto-1 expression in lung adenocarcinoma
por: Zhang, Hua, et al.
Publicado: (2017)

Clinical significance and biological function of fucosyltransferase 2 in lung adenocarcinoma
por: Zhou, Wenyuan, et al.
Publicado: (2017)

Expression of KLRG1 and CD127 defines distinct CD8(+) subsets that differentially impact patient outcome in follicular lymphoma
por: Wu, Hongyan, et al.
Publicado: (2021)

KLRG1 expression on natural killer cells is associated with HIV persistence, and its targeting promotes the reduction of the viral reservoir
por: Astorga-Gamaza, Antonio, et al.
Publicado: (2023)

IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential “inflammatory” type 2 innate lymphoid cells
por: Huang, Yuefeng, et al.
Publicado: (2014)

N-cadherin protects oral cancer cells from NK cell killing in the circulation by inducing NK cell functional exhaustion via the KLRG1 receptor
por: Lou, Chao, et al.
Publicado: (2022)

Endothelial cell-derived SSAO can increase MLC(20) phosphorylation in VSMCs
por: Zhang, Yuxing, et al.
Publicado: (2021)

Clinical significance of gefitinib antitumor activity in patients with lung adenocarcinoma
por: WANG, ZHUN, et al.
Publicado: (2015)

Increased expression of TIGIT and KLRG1 correlates with impaired CD56(bright) NK cell immunity in HPV16-related cervical intraepithelial neoplasia
por: Nie, You, et al.
Publicado: (2022)

Lgr5-positive cells in the lung and their clinical significance in patients with lung adenocarcinoma
por: Zhang, Xiaohan, et al.
Publicado: (2016)

KLRG1 and NKp46 discriminate subpopulations of human CD117(+)CRTH2(−) ILCs biased toward ILC2 or ILC3
por: Nagasawa, Maho, et al.
Publicado: (2019)

KLRG1 and CD103 Expressions Define Distinct Intestinal Tissue-Resident Memory CD8 T Cell Subsets Modulated in Crohn's Disease
por: Bottois, Hugo, et al.
Publicado: (2020)

Polyfunctional KLRG-1(+)CD57(+) Senescent CD4(+) T Cells Infiltrate Tumors and Are Expanded in Peripheral Blood From Breast Cancer Patients
por: Ramello, Maria C., et al.
Publicado: (2021)

Clinical and functional significance of a novel ferroptosis‐related prognosis signature in lung adenocarcinoma
por: Wang, Ziqi, et al.
Publicado: (2021)

Analysis of Expression and Its Clinical Significance of the Secreted Phosphoprotein 1 in Lung Adenocarcinoma
por: Guo, Zixin, et al.
Publicado: (2020)

N6-methyladenine- induced LINC00667 promoted breast cancer progression through m6A/KIAA1429 positive feedback loop
por: Ren, Saiyu, et al.
Publicado: (2022)

Correction: KLRG1 and NKp46 discriminate subpopulations of human CD117(+)CRTH2(−) ILCs biased toward ILC2 or ILC3
por: Nagasawa, Maho, et al.
Publicado: (2019)

Immunotherapy response and microenvironment provide biomarkers of immunotherapy options for patients with lung adenocarcinoma
por: Zhan, Xue, et al.
Publicado: (2022)

Clinically significant mutations in HIV-infected patients with lung adenocarcinoma
por: Thaler, Jonathan, et al.
Publicado: (2017)

Coexpression of PD-1, 2B4, CD160 and KLRG1 on Exhausted HCV-Specific CD8+ T Cells Is Linked to Antigen Recognition and T Cell Differentiation
por: Bengsch, Bertram, et al.
Publicado: (2010)

Functional significance of U2AF1 S34F mutations in lung adenocarcinomas
por: Esfahani, Mohammad S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_28ici1bm32inlra0rqln1qjavv